SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
AMENDMENT TO
QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For The Quarter Ended June 30, 1999 Commission File No. 0-6994
------
NEW BRUNSWICK SCIENTIFIC CO., INC.
State of Incorporation - New Jersey E. I. #22-1630072
-----------
44 Talmadge Road, Edison, N.J. 08818-4005
Registrant's Telephone Number: 732-287-1200
------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding twelve (12) months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past ninety (90) days.
Yes X No
--- ---
There are 5,325,552 Common shares outstanding as of August 3, 1999.
1
<PAGE>
Item 6. Exhibits and Reports on Form 8-K
------------------------------------------------
The exhibits to this report are listed on the Exhibit Index included elsewhere
herein.
No reports on Form 8-K have been filed during the quarter ended June 30, 1999.
13
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this amended report to be signed on its behalf
by the undersigned thereunto duly authorized.
NEW BRUNSWICK SCIENTIFIC CO., INC.
--------------------------------------
(Registrant)
Date: August 14, 2000 /s/ David Freedman
-------------------
David Freedman
Chairman
(Chief Executive Officer)
/s/ Samuel Eichenbaum
-----------------------
Samuel Eichenbaum
Vice President - Finance
(Principal Accounting Officer)
14
<PAGE>
<TABLE>
<CAPTION>
NEW BRUNSWICK SCIENTIFIC CO., INC. AND SUBSIDIARIES
EXHIBIT INDEX
-----------------
Exhibit No Exhibit Page No.
---------- ------- --------
<S> <C> <C>
Research and Licensing Agreement
Between DGI BioTechnologies LLC.
And Novo Nordisk A/S dated May 28
1999 [Confidential portions of this
document have been omitted and
filed separately with the Commission
pursuant to a confidential treatment
request by Registrant dated August 14,
2000. This document (with additional
portions of Section 1.6 omitted) was
originally filed as Exhibit 10-18 to
Registrant's Form 10-Q for period
10.18 Ending June 30, 1999] 1
Credit Agreement Between New
Brunswick Scientific Co., Inc. and
First Union National Bank dated
10.19 April 1, 1999 (filed 08/16/99)
Financial Data Schedule
(Filed- electronically with SEC only
27 (filed 08/16/99)
</TABLE>
15
<PAGE>
